Serum MSAs were comprehensively measured using IP assay in PM/DM-ILD patients. Anti-ARS and anti-MDA5 antibodies were the two major MSAs in PM/DM-ILD. Clinical and radiographical features were different among the MSA subgroups. Assessment of MSAs may be useful for predicting the clinical course and prognosis.